Our data suggest that reduced capacity of GLP-1(936) to exert its glucagonostatic effect might contribute to this defect and exacerbate the hyperglycaemia caused by impaired insulin secretion
medical organizations for youth with OUD and stimulant use disorders (StUD)
Theoretical synergy: three pathways working together Triple-pathway hypothesis: Why it might work: Non-overlapping receptor pathways Complementary not redundant Multiple appetite suppression mechanisms Enhanced metabolic effects Potential for greater weight loss than either alone Comparison to proven combinations: CagriSema (semaglutide + cagrilintide): 15-25% proven Tirzepatide alone: 15-22% proven Theoretical tirzepatide + cagrilintide: 20-30% unproven The critical problem: no clinical data What we DON'T know: Is the combination safe
*Correspondence: Pei Pei Chong, [email protected] This article was submitted to Microbial Symbioses, a section of the journal Frontiers in Microbiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Medical supervision may be advisable in severe renal impairment
An airless pump packaging would really seal the deal but this is still absolutely a sunscreen I would recommend to anyone looking for great protection and a light, non-greasy finish